Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

NRC:Improving Healthcare for Cognitively Impaired Elders and Their Caregivers (RDAD&APNs)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03289377
Recruitment Status : Unknown
Verified May 2018 by Linda Teri, University of Washington.
Recruitment status was:  Recruiting
First Posted : September 21, 2017
Last Update Posted : May 15, 2018
Sponsor:
Information provided by (Responsible Party):
Linda Teri, University of Washington

Brief Summary:
An multi-stage mixed-method design will be employed to obtain both qualitative and quantitative data to address two study aims: (1) Evaluate and refine the delivery Reducing Disabilities in Alzheimer's Disease (RD- AD) training to advanced practice nurses and (2) Evaluate and refine the implementation of RD-AD by advanced practice nurses in their medical settings.

Condition or disease Intervention/treatment Phase
Alzheimer Disease Nurse Training Behavioral: RDAD Training Not Applicable

Detailed Description:

Two waves of APNs (25 each wave/total 50) will receive RDAD training and be queried pre and post- training using both qualitative and quantitative procedures to determine: (1) Is RDAD training successfully received by advanced practice nurses? (2) Do they report it as relevant to improving the care they deliver to persons with Alzheimer's Disease and Related Dementias (ADRD)? (3) Does RDAD training of advanced practice nurses improve their level of knowledge about ADRD, their skills in providing ADRD care, and their level of confidence in providing this care?

A subset of advanced practice nurses (5 per wave, total of 10) will be recruited to implement RDAD as part of their ongoing care of persons with ADRD.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 50 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: NRC: Improving Healthcare for Cognitively Impaired Elders and Their Caregivers
Actual Study Start Date : February 1, 2018
Estimated Primary Completion Date : October 2018
Estimated Study Completion Date : October 2018


Arm Intervention/treatment
Experimental: RDAD training to APNs
Half-day workshop to provide APNs with all skills necessary to conduct RDAD in their clinical settings. A subset of the trained APNs will implement RDAD as part of their ongoing care of persons with ADRD.
Behavioral: RDAD Training
An interactive processes of lecture, role-play, and discussion, APNs will have the opportunity to dissect all phases of RDAD to insure they understand the objectives, can enact the program, and feel confident they can problem-solve situations that arise. APNs will receive materials to insure they are knowledgeable about ADRD symptoms, behavior management techniques, and exercise safety.




Primary Outcome Measures :
  1. Physician Confidence in Dementia Care Skills [ Time Frame: Change from baseline score at 2 months ]
    A 12-item self-report measure (administered to ARNPs) designed to measure perception of ability to address the care needs of patients with ADRD.

  2. Sense of Competence in Dementia [ Time Frame: Change from baseline score at 2 months ]
    A 17-item questionnaire covering 4 domains: job satisfaction, attitude towards dementia, work experience, and level of dementia knowledge.

  3. Dementia Attitudes Scale [ Time Frame: Change from baseline score at 2 months ]
    A 20-item scale to measures attitudes towards dementia with a two-factor structure; "dementia knowledge" and "social comfort".


Secondary Outcome Measures :
  1. Focus Group Questions [ Time Frame: At 2 months ]
    Questions to determine satisfaction with a acceptability of RDAD

  2. Implementation Questions [ Time Frame: At 2 months ]
    Questions to determine Acceptability of RDAD



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Licensed by the Washington state Department of Health as an Advanced Registered Nurse Practitioner (ARNP),
  • Hold a board certification as a Gerontological Nurse Practitioner, Adult Nurse Practitioner, or Family Nurse Practitioner,
  • Work at least half time (0.50 FTE) in a clinical setting (primary care, internal medicine, sub-specialty, medical home), with a panel consisting of over 25% of patients over 65 years of age,
  • Have no expectation for termination over the course of the study; and
  • Agree to participate in all phases of the RDAD translational program.

Exclusion Criteria:

  • NA

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03289377


Contacts
Layout table for location contacts
Contact: Christine A Coulter, Ph.D. 206-685-9169 cac76@uw.edu
Contact: Amy L Cunningham, M.S. 206-616-5550 amoore@uw.edu

Locations
Layout table for location information
United States, Washington
University of Washington Recruiting
Seattle, Washington, United States, 98195
Contact: Amy Moore Cunningham, MS    206-616-5550    amoore@u.washington.edu   
Principal Investigator: Linda Teri, Ph.D.         
Sponsors and Collaborators
University of Washington
Investigators
Layout table for investigator information
Principal Investigator: Linda Teri, Ph.D. University of Washington
Additional Information:
Publications:

Layout table for additonal information
Responsible Party: Linda Teri, Professor, School of Nursing, University of Washington
ClinicalTrials.gov Identifier: NCT03289377    
Other Study ID Numbers: STUDY00003731
First Posted: September 21, 2017    Key Record Dates
Last Update Posted: May 15, 2018
Last Verified: May 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Alzheimer Disease
Dementia
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Tauopathies
Neurodegenerative Diseases
Neurocognitive Disorders
Mental Disorders